1) experimental IgA nephropathy
实验性IgA肾病
1.
Effects of leflunomide on renal pathology and expression of MCP-1 in renal tissue in rat experimental IgA nephropathy model;
Leflunomide对实验性IgA肾病大鼠肾脏病理及MCP-1表达的影响
2.
Objective:To explore traditional Chinese medicine Rosa Laevigata Michx extract liquid on the treatment of experimental IgA nephropathy,understanding its mechanism.
目的:探索传统中药金樱子(Rosa Laeviga Michx,RLM)水醇提取液对实验性IgA肾病的治疗作用,了解其作用机制。
2) secondary IgA nephropathy
继发性IgA肾病
1.
Objective:To investigate the etiology, histopathological and immunofluorescence features in patients with secondary IgA nephropathy.
目的:分析继发性IgA肾病(IgAN)的病因、肾活检组织学及免疫病理特征。
3) primary IgA nephropathy
原发性IgA肾病
1.
Objective: to study the clinico-pathological features in xinjiang uigur and Chinese patients with primary IgA nephropathy.
目的：初步探讨新疆维吾尔族和汉族原发性IgA肾病临床及病理特点；方法：对1999年6月至2005年12月在新疆维吾尔自治区人民医院肾内科住院并经肾活检确诊的维吾尔族和汉族原发性IgA肾病患者进行流行病学，临床表现及病理特征的回顾性分析；结果：维吾尔族和汉族原发性IgA肾病患者分别为46例和71例，分别占同期同民族原发性肾小球疾病的17。
2.
Results Primary IgA nephropathy with low complement C3 hyperlipidemia and no significant correlation between the clinical manifestations,X2 test there was no significant difference.
目的探讨原发性IgA肾病与低补体血症的关系。
6) IgA nephropathy
IgA肾病
1.
Correlation of plasminogen activator and plasminogen active inhibitor expression and capillary density in IgA nephropathy.;
纤溶酶原激活物及其抑制剂-1表达与IgA肾病毛细血管密度相关关系的研究
2.
Isolate culture of Mycoplasma penetrans in blood,urine and throat of IgA nephropathy patients;
IgA肾病患者血液、尿液及咽拭子标本中穿通支原体的分离检出
3.
Effect of urokinase on capillary density in IgA nephropathy;
尿激酶对IgA肾病毛细血管密度的影响
补充资料：多发性骨髓瘤性肾病
多发性骨髓瘤性肾病
multiple myeloma nephropathy
继发于多发性骨髓瘤的肾损害。骨髓瘤可由多种途径损害肾脏，包括：①凝溶蛋白对肾小管的损害；②轻链在肾小球系膜区的沉积；③继发肾淀粉样变；④溶骨引起的高钙性肾病及瘤组织破坏引起的高尿酸肾病等。治疗应以治疗骨髓瘤为主。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条